Physician profile
Saba E Mattern
NPI 1912081514
$10,766.51
in general payments reported to CMS, 2019-2025
22 companies · $938 in 2025
The $938 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,542 · 2020: $258 · 2021: $1,361 · 2022: $1,135 · 2023: $1,505 · 2024: $1,028 · 2025: $938.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,470.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $4,292.23 | 2019-2025 | Total30, Precision 1, Dailies Total1 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $2,000.21 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $1,389.37 | 2022-2025 | Miebo, Xiidra, Infuse |
| Johnson & Johnson Surgical Vision, INC. | $708.15 | 2019 | |
| Oyster Point Pharma, INC. | $446.22 | 2022-2024 | Tyrvaya |
| Johnson & Johnson Vision Care, INC. | $446.19 | 2019-2023 | Acuvue |
| Tarsus Pharmaceuticals, INC. | $440.33 | 2024-2025 | Xdemvy |
| Coopervision INC. | $210.16 | 2019-2021 | |
| Dompe US, INC. | $165.66 | 2024-2025 | Oxervate |
| Abb Con-Cise Optical Group LLC | $129.90 | 2019-2022 | |
| Heru, INC. | $114.72 | 2022 | |
| Optovue, INC. | $96.62 | 2019 | |
| Novartis Pharmaceuticals Corporation | $78.59 | 2020-2023 | |
| Carl Zeiss Meditec USA, INC. | $55.11 | 2022 | |
| Alcon Research LLC | $49.36 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $29.43 | 2022 | |
| Kala Pharmaceuticals, INC. | $24.25 | 2021 | |
| Sun Pharmaceutical Industries INC. | $20.00 | 2020 | |
| Glaukos Corporation | $19.54 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Shire North American Group INC | $16.45 | 2019 | |
| Harrow Eye, LLC | $14.62 | 2025 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saba Mattern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.